Meanwhile, by sponging miR-216a, MEG3 enhances programmed death-1 (PD-1) expression while suppressing EMT inducer myeloid cell leukemia-1 (MCL-1) in endometrial cancer cells [113]. This evidence concerns the gene MCL1 and endometrial cancer.